Italian reference price cuts invalidated, but still on the agenda
This article was originally published in Clinica
Executive Summary
Medtech suppliers in Italy can breathe a sigh of relief after government plans to enforce cuts in existing contract prices have been ruled unlawful. The ruling, passed by a regional court but with national impact, means that the much-criticized reference pricing calculation, due to have come into force in January, is on hold – at least for the time being. Price cuts are still on the agenda but Italy’s legislators now need to redefine the methodology for implementing these cuts.